These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8583857)

  • 41. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
    Zhang E; Gong S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation characteristics of cholesteatoma epithelium determined by expression of transglutaminase isoenzymes.
    Chang CS; Jun BH; Song KY; Kim IG
    J Korean Med Sci; 1999 Dec; 14(6):665-70. PubMed ID: 10642946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heat shock proteins in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.
    Park M; Lee B; Lee J
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):221-7. PubMed ID: 23900149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.
    Xie S; Pan Z; Yin T; Ren J; Liu W
    Acta Otolaryngol; 2020 May; 140(5):351-355. PubMed ID: 32108533
    [No Abstract]   [Full Text] [Related]  

  • 46. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
    Xu Y; Wu Z; Tao Z; Hua Q; Jin K
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
    Li Z; Li X; Liu G
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expressions of TRPVs in the cholesteatoma epithelium.
    Do BH; Koizumi H; Ohbuchi T; Kawaguchi R; Suzuki H
    Acta Otolaryngol; 2017 Oct; 137(10):1039-1045. PubMed ID: 28599589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of tenascin in cholesteatoma and external auditory meatal skin compared to retroauricular epidermis.
    Schilling V; Lang S; Rasp G; Mack B; Nerlich A
    Acta Otolaryngol; 1996 Sep; 116(5):741-6. PubMed ID: 8908253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional characterization of middle ear mucosa residues in cholesteatoma samples.
    Sudhoff H; Bujía J; Holly A; Kim C; Fisseler-Eckhoff A
    Am J Otol; 1994 Mar; 15(2):217-21. PubMed ID: 8172304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of messenger RNA for keratinocyte growth factor in human cholesteatoma.
    Kojima H; Matsuhisa A; Shiwa M; Kamide Y; Nakamura M; Ohno T; Moriyama H
    Arch Otolaryngol Head Neck Surg; 1996 Feb; 122(2):157-60. PubMed ID: 8630209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
    Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
    Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between human beta defensin expression and cholesteatoma formation.
    Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
    Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
    Li H; Jiang P; Wang L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Autocrine growth mechanisms of cholesteatoma epithelium].
    Schilling V; Holly A; Bujía J; Schulz P
    Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative cytokeratin distribution patterns in cholesteatoma epithelium.
    Olszewska E; Sudhoff H
    Histol Histopathol; 2007 Jan; 22(1):37-42. PubMed ID: 17128409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.